Vcam1+ Fibro-adipogenic Progenitors Mark Fatty Infiltration in Chronic Limb Threatening Ischemia.
Qunsheng DaiChangxin WanYueyuan XuKaileen FeiLindsey A OlivereBrianna GarrettLeo AkersDerek T PetersJames OttoChristopher D KontosZhiceng JiYarui DiaoKevin W SoutherlandPublished in: bioRxiv : the preprint server for biology (2024)
Skeletal muscle health and function is a critical determinant of clinical outcomes in patients with peripheral arterial disease (PAD). Herein, we identify fatty infiltration, the ectopic deposition of adipocytes in skeletal muscle, as a histological hallmark of end-stage PAD, also known as chronic limb threatening ischemia (CLTI). Leveraging single cell transcriptome mapping in mouse models of PAD, we identify a pro-adipogenic mesenchymal stromal cell population marked by expression of Vcam1 (termed Vcam1+ FAPs) that expands in the ischemic limb. Mechanistically, we identify Sfrp1 and Nr3c1 as regulators of Vcam1+ FAP adipogenic differentiation. Loss of Sfrp1 and Nr3c1 impair Vcam1+ FAP differentiation into adipocytes in vitro . Finally, we show that Vcam1+ FAPs are enriched in human CLTI patients. Collectively, our results identify a pro-adipogenic FAP subpopulation in CLTI patients and provide a potential therapeutic target for muscle regeneration in PAD.
Keyphrases
- skeletal muscle
- single cell
- end stage renal disease
- ejection fraction
- newly diagnosed
- stem cells
- chronic kidney disease
- healthcare
- cell adhesion
- insulin resistance
- rna seq
- adipose tissue
- bone marrow
- peritoneal dialysis
- prognostic factors
- mesenchymal stem cells
- high resolution
- poor prognosis
- risk assessment
- transcription factor
- anti inflammatory
- cell therapy
- metabolic syndrome
- ischemia reperfusion injury
- genome wide